China's Kangtai gets approval for clinical trial of coronavirus vaccine candidate


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ China's Kangtai gets approval for clinical trial of coronavirus vaccine candidate
China's Kangtai Biological Products cleared for human trial while Chinese Academy of Medical Sciences vaccine candidate is in mid-stage trial.

China's Shenzhen Kangtai Biological Products said on Tuesday it planned to launch a clinical trial of its coronavirus vaccine candidate as soon as possible after it had obtained regulatory approval from the Chinese medical products regulator.

Kangtai's candidate triggered antibodies when tested in mice and monkeys, and vaccinated monkeys tolerated high levels of the coronavirus, the company said in a filing. The firm also said the manufacturing facility to produce its vaccine candidate was complete, pending tests and regulatory certification.

It comes amid a global rush for a vaccine against COVID-19 which has killed more than 1 million people worldwide.

The candidate is an inactivated vaccine - a traditional method of inoculation using the dead virus, which cannot replicate in human cells, to trigger an immune response. Inactivated vaccines have been used against other diseases such as measles in the past.

Three inactivated vaccine candidates against the coronavirus in China developed respectively by Sinovac Biotech and by two units of state-backed China National Biotec Group (CNBG), are already in final-stage trials and have obtained government approval for emergency use for limited groups of people.

A fourth inactivated vaccine from the Chinese Academy of Medical Sciences is in a mid-stage trial.

Kangtai also has a deal to make and supply mainland China with the vaccine candidate developed by AstraZeneca and researchers at the University of Oxford. The manufacturing facility for this vaccine candidate is expected to be completed by the end of 2020, Kangtai said.

At least 10 experimental vaccine projects led by Chinese scientists are in human trials, with four in the final stage of testing. Foreign vaccine developers such as BioNTech and Inovio have also partnered with Chinese firms to run clinical trials in China. 

Tags : #KangtaiBiologicalProducts #KangtaiVaccine #ChineseAcademyofMedicalSciences #LatestCovidVaccineNewsSep29 #ChinaCovidVaccineNewsSep28 #LatestPharmaNewsUpdateSep28

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026